StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences Renewable energy by Year

Renewable energy — On-site solar / self-generation (MWh)

Gilead Sciences Renewable energy: 7,049 in FY2025, down 16.1% from a year earlier.

Latest, FY2025
7,049
Period ended Dec 31, 2025
Change on a year earlier
-16.1%
8,398 in FY2024
History
7 years
Since FY2019
Sources
2
Documents cited below

Where the FY2025 figure comes from

“Self-generation 51 8,010 8,398 7,049”

Source: Gilead Sustainability / IR (environmental-sustainability-data-performance-tables.pdf) ↗

Reported in Gilead Environmental Sustainability Data Tables.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Gilead Sciences Renewable energy, annual FY2019–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/esg-energy-solar

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.